EU Initiatives and Report

EULAR develops evidence-based policy to inform Government decisions related to rheumatic musculoskeletal diseases and research and communicates views to key decision makers.


EULAR Presentation by Prof. Iagnocco to the EU-OSHA Steering Group, to raise awareness of EULAR and the importance of managing RMDs in the workplace

​read more ​


EULAR calls on governments in Europe to recognize the most vulnerable during COVID-19

​ read more ​


EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap

​ read more ​


Second consultation of EULAR Feedback on the EU Pharmaceuticals Strategy Roadmap

​ read more​​ ​


Related Information
EULAR Advocacy Newsletter 

EULAR is committed to bringing rheumatic and musculoskeletal diseases (RMDs) onto the EU's agenda. Sign up to the EULAR Advocacy newsletter to keep up with the changes that our organisation is working towards in the area of policy and legislation to help achieve better social and economic outcomes for the many millions of people affected by these chronic and debilitating diseases across Europe.

​Subscribe now ​


About EULAR Advocacy

EU Advocacy is a key activity for a European umbrella organisation like the European Alliance of Associations for Rheumatology (EULAR).

​See more ​


EULAR Advocacy Partnerships

EULAR is committed to partner with organisations and scientific medical societies at a EU and national level towards improving research funding, social policy legislation and quality of care; assisting advocacy actions on the national and international levels around rheumatic and musculoskeletal diseases (RMDs).

​See more ​


EULAR Advocacy Activities and Materials

In order to persuade governmental and EU key decision-makers supporting the European rheumatology community, EULAR Advocacy develops evidence-based materials about RMDs and communicates its position on key policies and legislation being discussed.

​See more ​


EU Parliament Interest Group on RMDs

The European Parliament Interest Group on Rheumatic and Musculoskeletal Diseases (RMDs) was created in 2009 on the occasion of World Arthritis Day (12 October) and was re-established during the current parliamentary term (2014-2019).

​See more ​


Links to other organisations

Partnerships that help to increase the knowledge of the organisations involved and the impact they can have on the political stage.

​See more ​


RMD Definition

EULAR description on Rheumatic and Musculoskeletal Diseases (RMDs)

​See more ​